Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADA | P00813 | 1/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.63 |
| ▸ | LMNA | P02545 | 1/20 | 0.63 |
| ▸ | ALB | P02768 | 1/20 | 0.63 |
| ▸ | PI4KA | P42356 | 3/20 | 0.57 |
| ▸ | PI4K2B | Q8TCG2 | 3/20 | 0.57 |
| ▸ | PI4K2A | Q9BTU6 | 3/20 | 0.57 |
| ▸ | PI4KB | Q9UBF8 | 3/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | TP53 | P04637 | 1/20 | 0.57 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.57 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.57 |
| ▸ | APEX1 | P27695 | 1/20 | 0.57 |
| ▸ | BLM | P54132 | 1/20 | 0.57 |
| ▸ | ADCY1 | Q08828 | 1/20 | 0.57 |
| ▸ | ADORA3 | P0DMS8 | 6/20 | 0.56 |
| ▸ | ADORA2A | P29274 | 5/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9197787 | 1.00 | ADA (0.65) | ADAMAPK1ALDH1A1LMNAALB | |
| SCHEMBL18572374 | 1.00 | ADA (0.65) | ADAMAPK1ALDH1A1LMNAALB | |
| SCHEMBL29609293 | 1.00 | ADA (0.65) | ADAMAPK1ALDH1A1LMNAALB | |
| SCHEMBL10381269 | 1.00 | ADA (0.65) | ADAMAPK1ALDH1A1LMNAALB | |
| SCHEMBL1374909 | 1.00 | ADA (0.65) | ADAMAPK1ALDH1A1LMNAALB | |
| SCHEMBL8094890 | 1.00 | ADA (0.65) | ADAMAPK1ALDH1A1LMNAALB | |
| SCHEMBL20419221 | 1.00 | ADA (0.65) | ADAMAPK1ALDH1A1LMNAALB | |
| Phosphoric Acid SCHEMBL8630949 | 0.94 | MAPK1 (0.60) | ADAMAPK1ALDH1A1LMNAALB | |
| Phosphoric Acid SCHEMBL4966781 | 0.94 | MAPK1 (0.60) | ADAMAPK1ALDH1A1LMNAALB | |
| Phosphoric Acid SCHEMBL79814 | 0.94 | MAPK1 (0.60) | ADAMAPK1ALDH1A1LMNAALB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5590 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144879-A1 | ANTI-VIRAL AND HEPATIC-TARGETED DRUGS | AI-BIOPHARMA (FR) | 2026-05-28 | — | — | US | claimed |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| US-20260091068-A1 | METHODS FOR TREATING AND PREVENTING DISEASES | Tets, Viktor Veniaminovich (US) | 2026-04-02 | — | — | US | claimed |
| US-12576124-B2 | Formulation of a conjugate of a tubulysin analog to a cell-binding molecule | HANGZHOU DAC BIOTECH CO., LTD (CN) | 2026-03-17 | — | — | US | claimed |
| US-20260071254-A1 | POLYMERASE MEDIATED END MODIFICATION OF ABSEQ | BECTON DICKINSON CO (US) | 2026-03-12 | — | — | US | claimed |
| US-20250388958-A1 | COMPOSITIONS, KITS, AND METHODS FOR DETECTING NUCLEIC ACIDS USING INTRA-CHANNEL MULTIPLEXING | Life Technologies Corporation (US) | 2025-12-25 | — | — | US | claimed |
| US-20250339551-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE DIFFERENT FUNCTIONAL SMALL MOLECULES FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | HANGZHOU SEEHE BIOTECHNOLOGY CO., LTD (CN) | 2025-11-06 | — | — | US | claimed |
| EP-4642492-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE FUNCTIONAL SMALL MOLECULE COMPOUNDS FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | claimed |
| EP-4642484-A1 | TARGETED TREATMENT OF PROSTATE CANCERS AND OTHER TUMORS BY AN ANTIBODY-DRUG CONJUGATE | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | claimed |
| EP-4612322-A1 | POLYMERASE MEDIATED END MODIFICATION OF ABSEQ | Becton, Dickinson and Company (US) | 2025-09-10 | — | — | EP | claimed |
| WO-1989002733-A1 | LIPOSOMAL NUCLEOSIDE ANALOGUES FOR TREATING AIDS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1989-04-06 | — | — | WO | claimed |
| EP-0296573-A2 | Novel nucleosides, their preparation and pharmaceutical compositions | F. HOFFMANN-LA ROCHE AG (CH) | 1988-12-28 | — | — | EP | claimed |
| WO-1988007544-A1 | INHIBITORS FOR REPLICATION OF RETROVIRUSES AND FOR THE EXPRESSION OF ONCOGENE PRODUCTS | UNITED STATES OF AMERICA, REPRESENTED BY THE UNITE (US) | 1988-10-06 | — | — | WO | claimed |
| EP-0272007-A2 | 5- and 6- Succinimidyl - carboxylate isomers of rhodamine dyes | APPLIED BIOSYSTEMS, INC. (US) | 1988-06-22 | — | — | EP | claimed |
| EP-0270317-A2 | Pharmaceutical compositions for the treatment of diseases caused by viruses | Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo (JP) | 1988-06-08 | — | — | EP | claimed |
| WO-1988002629-A1 | 2',3'-DIDESOXYADENOSINE COMPOSITION | AMERICAN HEALTH PRODUCTS CORPORATION (US) | 1988-04-21 | — | — | WO | claimed |
| US-4704357-A | TESTING DRUGS FOR EFFICARY AGAINST AIDS VIRUS | UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1987-11-03 | — | — | US | claimed |
| EP-0216510-A2 | Inhibition of in vitro infectivity and cytopathic effect of HTLV-III/LAV by 2'3'-dideoxyinosine, 2'3'-dideoxyguanosine, or 2'3'-dideoxyadenosine | THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce (US) | 1987-04-01 | — | — | EP | claimed |
| WO-1987001284-A1 | INHIBITION OF IN VITRO INFECTIVITY AND CYTOPATHIC EFFECT OF HTLV-III/LAV BY 2',3'-DIDEOXYNOSINE, 2',3'-DIDEOXYGUANOSINE, OR 2',3'-DIDEOXYADENOSINE | UNITED STATES OF AMERICA, REPRESENTED BY THE UNITE (US) | 1987-03-12 | — | — | WO | claimed |
| EP-0206497-A2 | Therapeutic nucleosides and their preparation | THE WELLCOME FOUNDATION LIMITED (GB) | 1986-12-30 | — | — | EP | claimed |